Dr. Kirti Shetty, MD

Dr. Shetty practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Shetty's NPI, 1669472429, was assigned on July 22, 2005. Dr. Shetty holds Maryland license D77038.

Dr. Shetty's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Shetty's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Shetty is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is Johns Hopkins Department of Orthopaedic Surgery. Dmand AI also links Dr. Shetty to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shetty practices, 3 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Shetty's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Shetty is licensed in Maryland.

CMS data shows 386 Medicare services from Dr. Shetty across 6 procedure codes in 2024, for 187 Medicare patients. Medicare paid $35,055 for them.

CMS counts 187 Medicare patients who saw Dr. Shetty in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shetty's median patient age at 62, with 49% women.

In 2024, Dr. Shetty wrote 251 Medicare Part D claims for 55 patients. 87% of them were for generic drugs. CMS names the drug for 160 of them, across 8 drugs with 11 or more claims each, at $75,218 in total drug cost. In 2023, CMS named 131 claims across 7 drugs.

Dr. Shetty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shetty as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 61 papers to Dr. Shetty, published from 2011 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Liver Transplantation. Dr. Shetty has published most often in Prog Transplant. Dr. Shetty's most frequent co-authors are Lopa Mishra, MD, Aiwu Ruth He, MD, PhD and Neha R. Jakhete, MD.

Dmand AI links Dr. Shetty to 4 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular and Fibrosis.

CMS Open Payments shows 60 general payments to Dr. Shetty from 11 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 41% of the total. Intercept Pharmaceuticals, Inc. paid the most, $5,374. It also lists 1 research payment totaling $6,278 in 2016.